000			03306cam a2200349 a 4500
003			EG-GiCUC
005			20250223032103.0
008			181020s2018 ua dh f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.19.04.M.Sc.2018.Re.C
100	0		_aReham Abdelreheem Abdelkader
245	1	0	_aClinicopatholgical and treatment outcome study of endometrial carcinoma retrospective study at National Cancer Institute (NCI) between years 2008-2012 / _cReham Abdelreheem Abdelkader ; Supervised Amany Mohamd Helal , Eman Loay Hussein , Hala Aziz Shokralla
246	1	5	_aدراسة اكلينيكية باثولوجية لمرضى أورام بطانه الرحم المترددين على المعهد القومى للاورام في الفترة من 2008 الي 2012
260			_aCairo : _bReham Abdelreheem Abdelkader , _c2018
300			_a85 P. : _bcharts , facsimiles ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology (Medical)
520			_aBackground: Endometrial adenocarcinoma are considered of the most common gyncolgical neoplasms. Efforts to reduce their high mortality rates are currently focused on multidisciplinary management, and considerable controversy has surrounded their management. Patients and methods: This study was a retrospective cohort study carried out on patients{u2019} files diagnosed with Endometrial adenocarcinoma between years 2008 to 2012. The study was carried out at the Medical Oncology Department of the National Cancer Institute, Cairo University. From the patients' records the following data were collected; Demographic data and medical history, results of physical examination, laboratory and radiological investigations, treatment modalities with its complications and outcomes. All these data were collected and statistically analyzed. Aim of work: Detection of Epidemiological, clinicopathological characteristics of all Endometrial adenocarcinoma cases. Evaluation of different treatment modalities, clinical response and outcomes of primary Endometrial adenocarcinoma cases in the form of overall survival & disease free survival. Results: This was a retrospective observational trial included 110 cases of all endometrial adenocarcinoma presented to or treated at NCI (from 2008 to 2012), 58 cases are full documented. All were histological confirmed and sub-typed. Conclusion: Most of Endometrial adenocarcinoma patients in this study present in early stage in the majority of cases, with variable survival rates according to demographic differences, performance status, staging, pathology and treatment modalities. Poor survival outcomes have been obtained from those with poor performance status, advanced stage, advanced age and those who have comorbidities
530			_aIssued also as CD
653		4	_aClinicopatholgical
653		4	_aEndometrial adenocarcinoma
653		4	_aNational Cancer Institute (NCI)
700	0		_aAmany Mohamd Helal , _eSupervisor
700	0		_aEman Loay Hussein , _eSupervisor
700	0		_aHala Aziz Shokralla , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aShimaa _eCataloger
942			_2ddc _cTH
999			_c68081 _d68081